First Trust Advisors’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-39,571
Closed -$1.76M 2401
2023
Q3
$1.76M Sell
39,571
-13,862
-26% -$605K ﹤0.01% 1738
2023
Q2
$2.32M Buy
+53,433
New +$2.35M ﹤0.01% 1630
2021
Q4
Sell
-16,863
Closed -$711K 2571
2021
Q3
$711K Buy
+16,863
New +$849K ﹤0.01% 2163
2020
Q4
Sell
-16,011
Closed -$788K 2386
2020
Q3
$788K Sell
16,011
-71
-0.4% -$3.93K ﹤0.01% 1861
2020
Q2
$936K Sell
16,082
-10,371
-39% -$548K ﹤0.01% 1763
2020
Q1
$1.2M Sell
26,453
-13,947
-35% -$838K ﹤0.01% 1524
2019
Q4
$2.66M Buy
+40,400
New +$2.47M ﹤0.01% 1414

Other funds holding NRC

First Trust Advisors's NRC Position: Q4 2023 in Review

First Trust Advisors sold out of NRC Health Common Stock (NRC) in Q4 2023, closing a stake of 39,571 shares — an estimated $1.76M sold.

First Trust Advisors first reported a position in NRC in Q4 2019 and held it in 7 quarters. The position peaked at $2.66M in Q4 2019. 132 funds tracked by Wall St. Rank hold NRC as of Q4 2023.

  • First Trust Advisors reported no remaining NRC Health Common Stock position as of Q4 2023 after selling out during the quarter.
  • First Trust Advisors sold 39,571 NRC Health Common Stock shares in Q4 2023, an estimated $1.76M.
  • First Trust Advisors first reported a position in NRC Health Common Stock in Q4 2019 and held it in 7 quarters.
  • First Trust Advisors's NRC Health Common Stock position peaked at $2.66M in Q4 2019.
  • 132 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2023.

Based on First Trust Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.